Cargando…
Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
BACKGROUND: Endoscopic resection is increasingly used to treat pathological T1 (pT1) esophageal cancer (EC) patients. However, the procedures are limited by lymph node metastasis (LNM) and remain controversial. We aimed to construct a nomogram to predict the risk of LNM in patients with pT1 esophage...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186726/ https://www.ncbi.nlm.nih.gov/pubmed/32355736 http://dx.doi.org/10.21037/atm.2020.02.185 |
_version_ | 1783527015022854144 |
---|---|
author | Tian, Dong Jiang, Kai-Yuan Huang, Heng Jian, Shun-Hai Zheng, Yin-Bin Guo, Xiao-Guang Li, Hong-Yun Zhang, Jing-Qiu Guo, Ke-Xuan Wen, Hong-Ying |
author_facet | Tian, Dong Jiang, Kai-Yuan Huang, Heng Jian, Shun-Hai Zheng, Yin-Bin Guo, Xiao-Guang Li, Hong-Yun Zhang, Jing-Qiu Guo, Ke-Xuan Wen, Hong-Ying |
author_sort | Tian, Dong |
collection | PubMed |
description | BACKGROUND: Endoscopic resection is increasingly used to treat pathological T1 (pT1) esophageal cancer (EC) patients. However, the procedures are limited by lymph node metastasis (LNM) and remain controversial. We aimed to construct a nomogram to predict the risk of LNM in patients with pT1 esophageal squamous cell carcinoma (ESCC). METHODS: A total of 243 patients with pT1 ESCC who underwent esophagectomy and lymph node dissection at two different institutes between February 2013 and June 2019 were analyzed retrospectively. Patients were categorized into the negative group and the positive group according to whether there was LNM. Risk factors for LNM were evaluated by univariate and multivariate analyses. The nomogram was used to estimate the individual risk of LNM. RESULTS: Forty-six (18.9%) of the 243 patients with pT1 ESCC exhibited LNM. The LNM rate in patients with stage T1a disease was 5.7% (5/88), and the rate in patients with stage T1b disease was 26.5% (41/155). Multivariable logistic regression analysis showed that tumor differentiation [odds ratio (OR) =1.942, 95% confidence interval (CI): 1.067–3.536, P=0.030], the T1 sub-stage (OR =4.750, 95% CI: 1.658–13.611, P=0.004), the preoperative alanine aminotransferase/aspartate aminotransferase ratio (LSR) (OR =5.371, 95% CI: 1.676–17.210, P=0.005), and the high-density lipoprotein cholesterol (HDL-C) level (OR =5.894, 95% CI: 1.917–18.124, P=0.002) were independent risk factors for LNM. The nomogram had relatively high accuracy, with an area under the receiver operating characteristic curve (AUC) of 0.803 (95% CI: 0.732–0.873). The calibration curve showed that the predicted probability of LNM was in good agreement with the actual probability. CONCLUSIONS: Clinicopathological and hematological parameters of tumor differentiation, the T1 sub-stage, the preoperative LSR, and the HDL-C level may predict the risk of LNM in T1 ESCC. The risk of LNM can be predicted by the nomogram. |
format | Online Article Text |
id | pubmed-7186726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-71867262020-04-30 Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study Tian, Dong Jiang, Kai-Yuan Huang, Heng Jian, Shun-Hai Zheng, Yin-Bin Guo, Xiao-Guang Li, Hong-Yun Zhang, Jing-Qiu Guo, Ke-Xuan Wen, Hong-Ying Ann Transl Med Original Article BACKGROUND: Endoscopic resection is increasingly used to treat pathological T1 (pT1) esophageal cancer (EC) patients. However, the procedures are limited by lymph node metastasis (LNM) and remain controversial. We aimed to construct a nomogram to predict the risk of LNM in patients with pT1 esophageal squamous cell carcinoma (ESCC). METHODS: A total of 243 patients with pT1 ESCC who underwent esophagectomy and lymph node dissection at two different institutes between February 2013 and June 2019 were analyzed retrospectively. Patients were categorized into the negative group and the positive group according to whether there was LNM. Risk factors for LNM were evaluated by univariate and multivariate analyses. The nomogram was used to estimate the individual risk of LNM. RESULTS: Forty-six (18.9%) of the 243 patients with pT1 ESCC exhibited LNM. The LNM rate in patients with stage T1a disease was 5.7% (5/88), and the rate in patients with stage T1b disease was 26.5% (41/155). Multivariable logistic regression analysis showed that tumor differentiation [odds ratio (OR) =1.942, 95% confidence interval (CI): 1.067–3.536, P=0.030], the T1 sub-stage (OR =4.750, 95% CI: 1.658–13.611, P=0.004), the preoperative alanine aminotransferase/aspartate aminotransferase ratio (LSR) (OR =5.371, 95% CI: 1.676–17.210, P=0.005), and the high-density lipoprotein cholesterol (HDL-C) level (OR =5.894, 95% CI: 1.917–18.124, P=0.002) were independent risk factors for LNM. The nomogram had relatively high accuracy, with an area under the receiver operating characteristic curve (AUC) of 0.803 (95% CI: 0.732–0.873). The calibration curve showed that the predicted probability of LNM was in good agreement with the actual probability. CONCLUSIONS: Clinicopathological and hematological parameters of tumor differentiation, the T1 sub-stage, the preoperative LSR, and the HDL-C level may predict the risk of LNM in T1 ESCC. The risk of LNM can be predicted by the nomogram. AME Publishing Company 2020-03 /pmc/articles/PMC7186726/ /pubmed/32355736 http://dx.doi.org/10.21037/atm.2020.02.185 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Tian, Dong Jiang, Kai-Yuan Huang, Heng Jian, Shun-Hai Zheng, Yin-Bin Guo, Xiao-Guang Li, Hong-Yun Zhang, Jing-Qiu Guo, Ke-Xuan Wen, Hong-Ying Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study |
title | Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study |
title_full | Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study |
title_fullStr | Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study |
title_full_unstemmed | Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study |
title_short | Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study |
title_sort | clinical nomogram for lymph node metastasis in pathological t1 esophageal squamous cell carcinoma: a multicenter retrospective study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186726/ https://www.ncbi.nlm.nih.gov/pubmed/32355736 http://dx.doi.org/10.21037/atm.2020.02.185 |
work_keys_str_mv | AT tiandong clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT jiangkaiyuan clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT huangheng clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT jianshunhai clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT zhengyinbin clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT guoxiaoguang clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT lihongyun clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT zhangjingqiu clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT guokexuan clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy AT wenhongying clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy |